Cytocom in proposed merger with Cleveland BioLabs after SEC filing

Cytocom in proposed merger with Cleveland BioLabs after SEC filing

FORT COLLINS/ BUFFALO, N.Y. -- New York-based Cleveland BioLabs, Inc. (NASDAQ: CBLI), a biopharmaceutical company developing novel approaches to activate the immune system, filed a registration... Read More

Thursday February 18, 2021 0 comments Tags: Fort Collins, Cytocom, Cleveland BioLabs, Michael Handley